Imbruvica Ibrutinib 140mg Sourcing BfArM Section 73 3 Regulations and Mantle Cell Lymphoma Care in Germany 2026
Author: Dr. James Nakamura
On August 22, 2026, German hematology societies updated sourcing guidelines for oral Bruton's tyrosine kinase (BTK) inhibitors. For patients managing Mantle Cell Lymphoma (MCL) or CLL, sourcing authentic options like Imbruvica (Ibrutinib) 140mg Capsules is essential for disease management.
At Onco Medicine, we specialize in delivering authentic, batch-verified oncology options directly to pharmacies and clinics in Germany under AMG rules.
BTK Inhibition in B-cell Malignancies
Ibrutinib binds covalently to Bruton's tyrosine kinase (BTK), shutting down B-cell receptor signaling:
- BTK Pathway Blockade: Inhibits B-cell proliferation and survival, keeping malignant cells from dividing.
- Dosing Protocol: The standard dose for MCL is 560mg (four 140mg capsules) taken orally once daily with water.
- Side Effect Management: Requires close monitoring for bleeding risk and atrial fibrillation during therapy.
BfArM AMG Section 73(3) Sourcing in Germany
German pharmacies can legally import specialized medications under the Section 73(3) AMG exemption:
- German Prescription: Sourcing requires a prescription from a German-licensed oncologist.
- Importation Documents: Every shipment includes a manufacturer COA, invoice, and prescription for custom check clearance.
- Temperature Control: Stored and shipped at room temperature (below 25°C), utilizing thermal insulation to prevent environmental extremes.
Secure Professional Sourcing & Support
For inquiries regarding batch availability, legal clearance documentation, or pricing details, please reach out to our dedicated support desk at support@onco-medicine.com. You can also connect directly with a qualified pharmacist via our verified WhatsApp Support Line at +91 94275 19809.



